Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:HSKA Heska (HSKA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Heska Stock (NASDAQ:HSKA) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Heska alerts:Sign Up Key Stats Today's Range$119.99▼$119.9950-Day Range$115.55▼$119.9952-Week Range$57.83▼$120.03VolumeN/AAverage Volume241,932 shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewHeska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.Read More… Receive HSKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter. Email Address HSKA Stock News HeadlinesVolitionRx Shares Up 35% on $13M Milestone Payments From HeskaJanuary 2, 2024 | marketwatch.comWhy Heska (HSKA) Hit a One-Year High TodayOctober 31, 2023 | thestreet.comHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.December 22, 2024 | Porter & Company (Ad)Why eXp World Holdings Shares Are Rising ThursdayJune 8, 2023 | markets.businessinsider.comHeska Earnings Perspective: Return On Capital EmployedMay 19, 2023 | msn.comHESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska ...May 11, 2023 | businesswire.comStrong Fourth Quarter Results Supported Heska Corporation (HSKA) in Q1May 9, 2023 | finance.yahoo.comHeska (HSKA) Q1 Earnings and Revenues Lag EstimatesMay 5, 2023 | finance.yahoo.comSee More Headlines HSKA Stock Analysis - Frequently Asked Questions How were Heska's earnings last quarter? Heska Co. (NASDAQ:HSKA) released its earnings results on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by $0.23. Heska's revenue for the quarter was up 6.4% on a year-over-year basis. What other stocks do shareholders of Heska own? Based on aggregate information from My MarketBeat watchlists, some other companies that Heska investors own include Netflix (NFLX), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD) and Home Depot (HD). Company Calendar Last Earnings11/04/2021Today12/22/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:HSKA CUSIPN/A CIK1038133 Webwww.heska.com Phone(970) 493-7272Fax970-619-3003Employees808Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E Ratio266.64 P/E GrowthN/ANet Income$-19,890,000.00 Net Margins-7.86% Pretax Margin-7.91% Return on Equity0.94% Return on Assets0.67% Debt Debt-to-Equity Ratio0.23 Current Ratio5.64 Quick Ratio4.12 Sales & Book Value Annual Sales$257.31 million Price / Sales5.09 Cash Flow$1.69 per share Price / Cash Flow70.99 Book Value$39.00 per share Price / Book3.08Miscellaneous Outstanding Shares10,910,000Free Float9,572,000Market Cap$1.31 billion OptionableNot Optionable Beta1.58 Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:HSKA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heska Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heska With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.